Skip to content
Recall Observatory FDA recall evidence

Drug product

Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90

D-0021-2023

October 05, 2022

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 90949
Status
Completed
Classification
Class II
Quantity
9504 bottles
Official record key
drug-enforcement:D-0021-2023

Official wording

Reason: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Code information: Lots QE2021005-A and QE2021010-A, exp 01/2023

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso-quinapril impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations